IPO GMP | New IPO open for investment, multibagger earning opportunity on first day, note IPO details – GMP IPO
IPO GMP | The IPO of Senorus Pharmaceuticals Limited Company has opened for investment from 20 December 2024. Senorus Pharmaceuticals Ltd to raise Rs 582.11 crore through IPO. Through this IPO the company will issue new shares worth Rs 1.29 crore. Apart from this, 21 lakh shares will be offered for sale by Senorus Pharmaceuticals Company. The IPO will remain open for investment till December 24.
IPO share price band
The price band for the IPO of Senorus Pharmaceuticals Limited Company has been fixed at Rs 372-391. Investors will get 38 shares in one lot of Senorus Pharmaceuticals IPO. This means that retail investors will have to invest at least Rs 14,858. The IPO of Senorus Pharmaceuticals Limited Company has reserved 75 percent stake for qualified institutional investors, 10 percent for retail investors and 15 percent for non-institutional investors. Senorus Pharmaceuticals has managed to raise Rs 260.63 crore from anchor investors through this IPO.
gray market premium
According to a report by InvestorsGains.com, the IPO stock of Senores Pharmaceuticals was trading at a premium of Rs 150 in the gray market on Friday. Therefore, there are signs of profit for investors at present. There has been no change in the GMP of Senorres Pharmaceuticals in the last few days.
About Senoras Pharmaceuticals Company
Senorus Pharmaceuticals Limited is a pharmaceutical company. Senoras Pharmaceuticals Company manufactures a variety of medicines. The business of Senorus Pharmaceuticals Limited company is also spread in major countries like America, Canada and United Kingdom. As of 30 September 2024, Senorus Pharmaceuticals Company has total of 55 products.
Disclaimer: Investing in mutual funds and stock market is based on risk. Before investing in the stock market, definitely consult your financial advisor. tezzbuzz.com will not be responsible for any financial loss.
Comments are closed.